Clinical trial complexity has increased significantly since 2000, with phase 3 study data volume rising by over 50% and per-patient costs nearly doubling, creating urgent need for streamlined operations.
The TAICHIKNEE trial, which assesses web-based Tai Chi for knee osteoarthritis, has updated its ethics and regulatory documentation after one year.
Industry experts at the Outsourcing in Clinical Trials Conference highlight promising signs of recovery in biotech venture financing, while regulatory reforms and pricing policies pose significant challenges.
A clinical trial demonstrated that dronabinol, a synthetic THC, significantly reduced agitation in Alzheimer's disease patients by 30%.
Leading pathologists highlight critical challenges in distinguishing between HER2-low and HER2-negative breast cancer cases, raising concerns about treatment decisions worth $100,000 or more.